First humans test new diabetes shot
NCT ID NCT06284798
Summary
This early study tested a single dose of a new, unapproved medicine called NNC0650-0013, which is being developed to potentially treat type 2 diabetes. The main goal was to check if the medicine is safe and to see how the body processes it. The study involved 11 healthy male volunteers who received either the medicine or a placebo as an injection under the skin or into a vein.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.